Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial

Completed · Phase 2/Phase 3

Conditions studied: Heart Failure

In brief

The purpose of the study is to determine the safety and effectiveness of the Jarvik 2000 Heart as a bridge to heart transplantation in end-stage heart failure patients who are approved heart transplant candidates.

Key facts

Study ID

NCT00591799

Run by

Jarvik Heart, Inc.

People needed

150

Starts

2005-04-01

Expected to finish

2012-05-01

Last updated by the study team

2013-09-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Maryland Medical Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.